Search Results 51-60 of 16253 for pharmacogenetics
“This association finding is a first step towards development of a pharmacogenetic test allowing physicians to choose appropriate treatment for specific ...
After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results ...
2023 - 2024. Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular ...
The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
About this study · The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management; · Patient perceptions, satisfaction and behaviors ...
The Mayo Clinic Center for Individualized Medicine's Clinomics Program accelerations the translation of genomic research into personalized patient care.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.